Brainstorm Cell (Germany) Top Insiders

GHDN Stock  EUR 2.69  0.00  0.00%   
Brainstorm Cell employs about 43 people. The company is managed by 9 executives with a total tenure of roughly 23 years, averaging almost 2.0 years of service per executive, having 4.78 employees per reported executive. Examination of Brainstorm Cell's management performance can provide insight into the company performance.
Chaim Lebovits  CEO
President CEO
Uri Yablonka  President
Executive Vice President Chief Business Officer, Director
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Brainstorm Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Brainstorm Cell Management Team Effectiveness

The company has return on total asset (ROA) of (0.6831) % which means that it has lost $0.6831 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.9343) %, meaning that it generated substantial loss on money invested by shareholders. Brainstorm Cell's management efficiency ratios could be used to measure how well Brainstorm Cell manages its routine affairs as well as how well it operates its assets and liabilities.

Brainstorm Cell Workforce Comparison

Brainstorm Cell Therapeutics is one of the top stocks in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 5,570. Brainstorm Cell maintains roughly 43.0 in number of employees contributing less than 1% to stocks in Biotechnology industry.

Brainstorm Cell Ther Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Brainstorm Cell Ther Price Series Summation is a cross summation of Brainstorm Cell price series and its benchmark/peer.

Brainstorm Cell Notable Stakeholders

A Brainstorm Cell stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Brainstorm Cell often face trade-offs trying to please all of them. Brainstorm Cell's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Brainstorm Cell's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Chaim LebovitsPresident CEOProfile
Uri YablonkaExecutive Vice President Chief Business Officer, DirectorProfile
Ralph KernCOO and Chief Medical OfficerProfile
Yael GothelfVP AffairsProfile
Irit DScCoFounder BoardProfile
Antal PearlLendnerVP CounselProfile
Daniel OffenChief AdvisorProfile
Stacy LindborgExec OfficerProfile
PharmD MBAEx COOProfile

About Brainstorm Cell Management Performance

The success or failure of an entity such as Brainstorm Cell Ther often depends on how effective the management is. Brainstorm Cell management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Brainstorm management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Brainstorm management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system adult stem cell therapies designed to address the unmet medical needs of patients with debilitating neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was founded in 2000 and is headquartered in New York, New York. BRAINSTORM operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 31 people.

Brainstorm Cell Workforce Analysis

Traditionally, organizations such as Brainstorm Cell use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Brainstorm Cell within its industry.

Brainstorm Cell Manpower Efficiency

Return on Brainstorm Cell Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee568.8K
Net Loss Per Executive2.7M

Complementary Tools for Brainstorm Stock analysis

When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio